Predictive markers in cancer therapy
作者： Sarah S Bacus , Michael T Stocum , Neil L Spector , Myra R Herrle , L Edward Kirk
DOI:
关键词:
摘要: Molecular markers useful in medicine response tests are provided, as an aid determining whether individual subject s tumor is responding to treatment with EGF and/or erbB2 inhibitors. Markers include phosphorylated ERK protein.
lens.org 参考文章(12)
Robert E. Brown, Proteomic analysis of tumors for development of consultative report of therapeutic options ,(2002)
Yuzo Ichimori, Akiyoshi Tani, Method for assaying ERK2 map kinase ,(1996)
Pamela A Davol, Raymond A Frackelton, SHC proteins as therapeutic targets in proliferative diseases ,(2004)
Eric A. Ariazi, Janet E. Mertz, Richard J. Kraus, Stephen D. Johnston, Method of using estrogen-related receptor alpha (ERRalpha) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRalpha as a therapeutic target for the treatment of breast cancer ,(2002)
Daniel Harari, Yosef Yarden, Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. ,vol. 19, pp. 6102- 6114 ,(2000) , 10.1038/SJ.ONC.1203973
Wenle Xia, Robert J Mullin, Barry R Keith, Lei-Hua Liu, Hong Ma, David W Rusnak, Gary Owens, Krystal J Alligood, Neil L Spector, Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways Oncogene. ,vol. 21, pp. 6255- 6263 ,(2002) , 10.1038/SJ.ONC.1205794
Julia M.W. Gee, John F.R. Robertson, Ian O. Ellis, Robert I. Nicholson, Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. International Journal of Cancer. ,vol. 95, pp. 247- 254 ,(2001) , 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S
Cecilia Suárez, Graciela Díaz-Torga, Arturo Gonzalez-Iglesias, Jorge Vela, Alejandro Mladovan, Alberto Baldi, Damasia Becu-Villalobos, Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells. American Journal of Physiology-endocrinology and Metabolism. ,vol. 285, pp. 645- 653 ,(2003) , 10.1152/AJPENDO.00015.2003
Jordi Codony-Servat, Judit Anido, Silvia Sauleda, Robert I. Nicholson, Joan Albanell, Federico Rojo, José Baselga, José M. Del Campo, José Roselló, John Mendelsohn, Jordi Giralt, Guillermo Raspall, Activated Extracellular Signal-regulated Kinases: Association with Epidermal Growth Factor Receptor/Transforming Growth Factor α Expression in Head and Neck Squamous Carcinoma and Inhibition by Anti-Epidermal Growth Factor Receptor Treatments Cancer Research. ,vol. 61, pp. 6500- 6510 ,(2001)